Research Triangle Park, North Carolina — According to state and local development sources, Biogen plans to invest $2 Billion to expand in Research Triangle Park. The company plans to occupy the new space at 5000 Davis Dr in Research Triangle Park, on or about October 1, 2027. According to the company website Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.

To learn more about Biogen, visit http://www.biogen.com/

Company Contact:
Christopher Viehbacher, Chief Executive Officer
781-464-2000

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.